Francis Laurencio reported a proposed resale under Form 144 of 6,610 shares of Common Stock arising from the vesting of restricted stock granted under the issuer's equity compensation plan on 06/01/2026. The filing lists Morgan Stanley Smith Barney LLC as the broker. The excerpt also shows a prior sale of 4,799 shares on 03/02/2026 for $23,748.12.
Atomera Incorporated filed Amendment No. 1 to a Schedule 13G reporting that CVI Investments, Inc. and Heights Capital Management, Inc. each report 0% beneficial ownership of the company's common stock as of 03/31/2026. The filing reiterates that Heights Capital Management serves as investment manager to CVI Investments and disclaims beneficial ownership except for a pecuniary interest. The amendment is signed by Sarah Travis on 05/13/2026.
Atomera Incorporated reported the results of its 2026 Annual Meeting of Stockholders held on May 12, 2026. Stockholders elected five directors — John Gerber, Scott Bibaud, Steve Shevick, Duy-Loan Le, and Suja Ramnath — with between about 11.9 million and 12.3 million votes cast in favor of each and 10,096,942 broker non-votes.
Stockholders also approved three additional proposals, which received 22,828,837, 20,981,009, and 11,523,530 votes in favor, respectively, with relatively low levels of opposition.
SHEVICK STEVEN K reported acquisition or exercise transactions in this Form 4 filing.
Atomera Inc director Steven K. Shevick reported an equity compensation grant. On May 12, 2026, he received 14,302 shares of common stock at a price of $0.00 per share as a grant or award, bringing his directly held common stock to 142,518 shares.
The award represents Restricted Stock Units of common stock issued on May 12, 2026, which will vest on May 11, 2027. The filing also shows an additional 2,200 common shares held indirectly by the Mackenzie Shevick Trust AG U/A dated November 10, 2020.
Atomera Inc director Suja Ramnath received an equity award in the form of 14,302 Restricted Stock Units (RSUs) of Common Stock on May 12, 2026. According to the disclosure, these RSUs will vest on May 11, 2027, meaning they convert into common shares on that date if conditions are met.
Following this grant, Ramnath’s direct holdings in Atomera common stock total 86,740 shares. The RSU award is compensation-related and was granted at a stated transaction price of $0.00 per share, rather than being an open-market purchase.
LE DUY LOAN T reported acquisition or exercise transactions in this Form 4 filing.
Atomera Inc director LE DUY LOAN T received a grant of 14,302 shares of Common Stock as a stock-based award. The grant was recorded at a price of $0.00 per share, reflecting compensation rather than an open-market purchase. After this award, the director holds 134,460 shares directly. According to the footnote, these are Restricted Stock Units issued on May 12, 2026 that will vest on May 11, 2027, meaning the shares are subject to a one-year vesting period.
Gerber John reported acquisition or exercise transactions in this Form 4 filing.
Atomera Inc director John Gerber received a compensation grant of 14,302 shares of Common Stock on May 12, 2026, in the form of Restricted Stock Units that will vest on May 11, 2027. The grant carried a stated price of $0.00 per share.
After this award, Gerber directly holds 332,569 shares of Atomera Common Stock. He also has indirect holdings, including 8,900 shares held by his spouse’s IRA, 156,196 shares held by his spouse, and 37,192 shares held by a partnership.
Atomera Incorporated reported a wider first-quarter net loss while significantly strengthening its balance sheet. Revenue for the three months ended March 31, 2026 was about $11,000, up from $4,000 a year earlier, mostly from engineering services tied to MST wafer deliveries. Operating expenses rose to roughly $6.2 million, driven by higher research and development, general and administrative, and selling and marketing costs, leading to a net loss of about $6.1 million, similar on a per-share basis at $(0.17).
Cash, cash equivalents and short-term investments totaled approximately $41.1 million with working capital near $39.9 million, helped by equity financing. During the quarter Atomera raised about $23.6 million of net proceeds from a registered direct offering of 5,000,000 shares at $5.00 per share and approximately $3.1 million from selling around 1.3 million shares through its 2025 at-the-market program. Management believes existing capital can fund operations for at least 24 months while the company continues to develop and license its MST® semiconductor technology.
Atomera Incorporated reported first quarter 2026 results showing continued investment and a wider loss while strengthening its balance sheet through new equity capital.
For the quarter ended March 31, 2026, revenue was $11 thousand and net loss was $6.1 million, or $0.17 per share, compared with a $5.2 million loss a year earlier. Adjusted EBITDA loss was $4.9 million. Cash, cash equivalents and short-term investments increased to $41.1 million, helped by a completed $25 million registered direct offering of common stock, and shares outstanding rose to 38.7 million.
Management highlighted progress in moving its MST technology into evaluation with additional Gate-All-Around transistor manufacturers and expanding its GaN technology into RF applications, positioning the company to support future MST-enabled products despite current low revenue and ongoing operating losses.